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Nephrotoxicity during aminoglycoside therapy
for infective endocarditis
L.E.A. Olaison, N. Johansson, U. Snygg-Martin, T.
Sandberg
Institute of Biomedicine, Sahlgrenska University
Hospital, Gothenburg, Sweden
Background:Aminoglycosides are commonly used in the treat-
ment of infective endocarditis (IE). Because of it′s nephrotoxic
potential it′s place in the treatment arsenal is currently being
debated.What is the potential risk of giving short-term therapy
(<10 days) vs longer treatment? Will concomitant vancomycin
therapy have an additive nephrotoxicity?
Methods & Materials: A cohort study of 128 consecutive
patientswith IE treatedat SahlgrenskaUniversityHospital,Gothen-
burg, Sweden 2007 through 2010 evaluated risk factors for kidney
dysfunction during treatment and follow-up. Kidney funtion was
assessed by estimated glomerular ﬁltration rate (eGFR) recorded
prior to, weekly during treatment, 1 month, 3 months and 1 year
post-treatment.
Results: A majority of patients (93%) received received combi-
nation therapy with tobramycin, 41% also received vancomycin.
There was a mean decrease of eGFR from 88.4 to 78.0mL/min
(-11.8%) from start of tobramycin treatment to 1 week post-
treatment. The decrease was accentuated 1 month post-treatment
(-12.4%). A gradual reversibility was recorded 3 months, and 1 year
post-treatment respectively.
Age, total dose of tobramycin, cardiac surgery, concomitant
treatment with potential renal toxic drugs, concomitant van-
comycin therapy, and elevated tobramycin serum concentrations
were associated with accentuated in-hospital decrease in eGFR.
Major risk factors for permanent decrease in kidney function
were established after subgroup analyses of comparable groups.
A total dose of >2500mg tobramycin implicated a decreased
reversibility of eGFR during 1-year F/U. Concomitant vancomycin +
tobramycin therapy caused a 19% loss in eGFR while no reduction
followed sequential vancomycin + tobramycin therapy. Patients
with an initial eGFR<39mL/min had the same decrease and
reversibility of renal function as patients with eGFR ≥40mL/min.
Patients with short-term therapy<10 days had no long-term
decrease in renal function.
Conclusion: Total dose of >2500mg tobramycin therapy caused
a decreased reversibility during 1-year F/U, while short-term ther-
apy<10 days had no impact on long-term kidney function.
http://dx.doi.org/10.1016/j.ijid.2014.03.1148
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Implant-associated infection after major
orthopaedic surgery: bioﬁlm production of
staphylococci
S. Bozhkova, M. Krasnova, E. Polyakova
Russian research institute of traumatology and
orthopedics named after R.R. Vreden, St-Petesrburg,
Russian Federation
Background: Staphylococci, especially S. aureus and S. epi-
dermidis remain the leading pathogens of the implant-associated
infection (IAI) after major orthopedic surgery due to their pro-
nounced ability to form the bioﬁlms onto orthopedic devices. The
aimof our studywas to evaluate the bioﬁlm forming ability of the S.
aureus and S. epidermidis strains collected from patients with IAI.
Methods & Materials: A hundred and ﬁve S.aureus and hundred
and seven of S. epidermidis strains were studied. The strains were
revealed fromculturesof samplesof soft tissue, aspirats or exsudate
aswell as from sonicated explanted devices from189 patientswith
orthopedic IAI. Antibiotic susceptibility was evaluated by Kirby-
Bauer method. We evaluated bioﬁlm formation by the microtiter
plate assay using the crystal violet staining described by Chris-
tensen et al. (1985), with minor modiﬁcations. All the strains were
tested in quadruplicate, and the average resulting OD values for
each strain were calculated. The bioﬁlm forming ability of staphy-
lococcal isolateswas considered such as strong (OD≥0.2),moderate
(0.2>OD≥ 0.15) and weak (OD<0.15).
Results: The obtained results demonstrate that 32.1% of S.
aureus and68.2%of S. epidermidis isolatesweremeticillin-resistant.
The strong bioﬁlm forming ability was detected in 33.4% of all
tested staphylococci, but 50.6% of the tested isolates were consid-
ered weak bioﬁlm formers. Independent of the sourses from which
staphylococci were revealed, its bioﬁlm forming ability appears to
depend on the type of staphylococci. The strong bioﬁlm forming
abilitywasdetected in35-55%of S. epidermidisandonly in28-29% S.
aureusobtained from different cultured samples. However found
55% of strains S. epidemidis recovered from explanted devices to be
intense bioﬁlm formers.
Conclusion: S. epidermidishas emerged as one of the most
important pathogen in IAI. It was shown S. epidermidis to
be more frequently meticillin resistant compared to the S.
aureus among IAI related staphylococci. There are also a sig-
niﬁcant difference between staphylococcal species in favor
of S. epidermidis in ability to form bioﬁlms. In addition, more than
a half of S. epidermidis strains isolated from removed devices tend
to have the strong ability to form bioﬁlms.
http://dx.doi.org/10.1016/j.ijid.2014.03.1149
